Claims
- 1. In a method of treating a site of a herpes virus infection, the step of topically applying to said infection site 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl] thiocarbonohydrazone or a pharmaceutically acceptable salt thereof.
- 2. In a method of treating a site of a topical herpes virus infection, in which acyclovir is used to treat the infection, the step of topically applying an effective amount of 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl] thiocarbonohydrazone to said site to potentiate the effect of acyclovir.
- 3. A method of treating a herpes virus infection in a mammal which comprises administering to said mammal an effective treatment amount of a compound 2-acetylpyridine 5-[(2-chloroanilino)thiocarbonyl]thiocarbonohydrazone or a pharmaceutically acceptable salt thereof.
- 4. The method of claim 1, in which the herpes virus infection is HSV1 or HSV2.
- 5. The method of claim 4, in which the compound or salt is applied topically.
- 6. The method of claim 1, in which the herpes infection is VZV.
- 7. The method of claim 6, in which the compound or salt is applied topically.
- 8. The method of claim 3, in which acyclovir is also administered to said mammal.
Priority Claims (1)
Number |
Date |
Country |
Kind |
8815241 |
Jun 1988 |
GBX |
|
Parent Case Info
This is a continuation of copending application Ser. No. 07/371,877 filed on Jun. 26, 1989, now U.S. Pat. No. 5,021,437.
US Referenced Citations (4)
Foreign Referenced Citations (1)
Number |
Date |
Country |
0135713 |
Apr 1985 |
EPX |
Non-Patent Literature Citations (1)
Entry |
Chemical Abstracts, vol. 103, No. 9, Abstract No. 76243x, Sep. 2, 1985, Averett et al. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
371877 |
Jun 1989 |
|